-
Phytochemical and biological activity studies of the Bhutanese medicinal plant corydalis crispa
- Back
Metadata
Document Title
Phytochemical and biological activity studies of the Bhutanese medicinal plant corydalis crispa
Author
Wangchuk P.,Keller P.A.,Pyne S.G.,Sastraruji T.,Taweechotipatr M.,Rattanajak R.,Tonsomboon A.,Kamchonwongpaisan S.
Name from Authors Collection
Affiliations
School of Chemistry, University of Wollongong, Wollongong, NSW, 2522, Australia; Pharmaceutical and Research Unit, Ministry of Health, Thimphu, Bhutan; Department of Microbiology, Faculty of Medicine, Srinakharinwirot University, Sukhumvit 23, Bangkok, 10110, Thailand; Medical Molecular Biology Research Unit, National Center for Genetic Engineering and Biotechnology, National Science and Technology Development Agency, Pathumthani, 12120, Thailand
Type
Article
Source Title
Natural Product Communications
ISSN
1934578X
Year
2012
Volume
7
Issue
5
Open Access
All Open Access, Bronze, Green
Publisher
Natural Product Incorporation
DOI
10.1177/1934578x1200700507
Abstract
The chemical constituents and biological activities of Corydalis crispa (Fumariaceae) were investigated for the first time. The phytochemical study resulted in the isolation of nine known isoquinoline alkaloids: protopine (1), 13-oxoprotopine (2), 13-oxocryptopine (3), stylopine (4), coreximine (5), rheagenine (6), ochrobirine (7), sibiricine (8) and bicuculline (9), with complete NMR data for 2 and 3 provided here for the first time. Crude extracts exhibited significant anti-inflammatory (p<0.01) activity against TNF-α production in LPS activated THP-1 cells. The acetylcholinesterase inhibitory activity of compounds 2, 4 and 7 and the antiplasmodial activity of compound 5 against P. falciparum strains TM4/8.2 and K1CB1 (multidrug resistant strain) are reported here for the first time. Stylopine (4) did not show antimalarial activity against the K1CB1 strain in contrast to a previous report. This study generated a scientific basis for the use of this plant in Bhutanese traditional medicine, either individually or in combination with other medicinal ingredients to treat a broad range of disorders. This study also identified compound 5 as potential new antimalarial lead compound.
Industrial Classification
Knowledge Taxonomy Level 1
Knowledge Taxonomy Level 2
Knowledge Taxonomy Level 3
License
CC BY-NC
Rights
SAGE Publishing
Publication Source
Scopus